title: Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.
authors.affiliation: Berlin, Germany.
authors.forename: O
authors.initials: O
authors.lastname: Hunsicker
authors.affiliation: Guildford, UK.
authors.forename: M J
authors.initials: MJ
authors.lastname: Scott
authors.affiliation: Durham, NC, USA.
authors.forename: T E
authors.initials: TE
authors.lastname: Miller
authors.affiliation: Montreal, QC, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Baldini
authors.affiliation: Berlin, Germany aarne.feldheiser@charite.de.
authors.forename: A
authors.initials: A
authors.lastname: Feldheiser
mesh_terms: D003102:Colloids / Q000627:therapeutic use*; D003107:Colorectal Surgery; D005260:Female; D005440:Fluid Therapy / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D007552:Isotonic Solutions / Q000627:therapeutic use*; D008297:Male
chemical_list: D003102:Colloids; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions